Clinical Trials Browser

Phase 4 × Overweight × Other × Clear all

NCT07462663 2026-05-13

SHAPE-ENDO

Phase 4 Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT07326111 2026-01-08

PERIODS

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome, Overweight

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT05518929 2024-06-07

SpO2

Phase 4 Completed

GastrointestinalOther

Obesity, Stomach Neoplasms, Stomach Ulcer, Overweight

NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Phase 4 Completed

70 enrolled 11 charts

Obesity, Polycystic Ovary Syndrome, Overweight

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

Phase 4 Completed

Obesity, Polycystic Ovary Syndrome, Overweight